Hironic Co., Ltd. (KOSDAQ:149980)
4,805.00
+15.00 (0.31%)
At close: Sep 11, 2026
Hironic Revenue
Hironic had revenue of 10.80B KRW in the quarter ending June 30, 2026, with 36.90% growth. This brings the company's revenue in the last twelve months to 37.10B, up 16.23% year-over-year. In the year 2025, Hironic had annual revenue of 32.09B with 1.45% growth.
Revenue (ttm)
37.10B
Revenue Growth
+16.23%
P/S Ratio
1.71
Revenue / Employee
317.07M
Employees
117
Market Cap
63.44B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.09B | 457.26M | 1.45% |
| Dec 31, 2024 | 31.63B | -2.10B | -6.24% |
| Dec 31, 2023 | 33.73B | 6.16B | 22.36% |
| Dec 31, 2022 | 27.57B | 5.79B | 26.57% |
| Dec 31, 2021 | 21.78B | 8.80B | 67.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 109.45B |
| Genoray | 107.88B |
| JPI Healthcare | 46.86B |
| L&K Biomed | 39.94B |
| SELVAS Healthcare | 31.69B |
| Remed | 27.05B |
| Dynamic solution | 15.11B |
| QuantaMatrix | 3.15B |